Feature | July 13, 2012

The Offbeat: Baby Not Harmed by Therapeutic Hypothermia During Pregnant Woman's Cardiac Arrest

July 13, 2012 ? An otherwise healthy pregnant woman who suffered cardiac arrest and was resuscitated, therapeutically cooled and then re-warmed, delivered a healthy, full-term baby 19 weeks later. Researchers published a unique case report online last week in Annals of Emergency Medicine.

"We have over years years of clinical follow-up of the mother and child and both are doing well, with the child exhibiting normal developmental growth at long-term follow-up," said lead author Aakash Chauhan, M.D., MBA, of Allegheny General Hospital in Pittsburgh, Penn. "The mother and child both had great outcomes despite an incredibly harrowing episode during her pregnancy."

The patient, a 33-year-old woman in her 20th week of pregnancy, suffered cardiac arrest while at a church gathering. She was given CPR, defibrillated and transported to the emergency department. Three hours after arriving at the hospital, the patient's body was cooled to approximately 90 degrees Fahrenheit.  She was kept at a hypothermic temperature for 12 hours and then rewarmed to a normal temperature.  While the patient was being cooled, doctors monitored the fetus and detected fetal shivering, which stopped once the mother was re-warmed. 

The patient stayed in the hospital for 10 more days and was implanted with a cardioverter-defibrillator (ICD).  She resumed her work and normal activities of daily living for the remainder of her pregnancy and delivered a healthy baby boy at 39 weeks. 

Doctors evaluated the boy at 1, 2, 3, 6, 12 and 36 months of age and found he has reached all the normal development milestones.

"We would not normally treat a rare cardiac arrest pregnant patient with hypothermia because hypothermia was untested in this population and therefore considered too risky for the fetus," said Naseer Nasser M.D., the cardiologist who directed her care at Memorial Hospital in South Bend, Indiana. "However, without the recently proven benefit of hypothermia for cardiac arrest, mother and child would not have benefited from this lifesaving advance. This report suggests that with prudent clinical judgment, vigilance and a dedicated multi-disciplinary team, therapeutic hypothermia can be offered to pregnant women who survive cardiac arrest."

Michael Donnino, M.D., of Beth Israel Deaconess Medical Center in Boston, Mass, a co-author of the paper who is a member of the advanced cardiac life support subcommittee at the American Heart Association (AHA), said, "Publishing this case will add to the paucity of literature on the safety of hypothermia in pregnancy and provide support for the AHA's current recommendation of 'may consider use' of hypothermia in pregnancy."

Annals of Emergency Medicine is the peer-reviewed scientific journal for the American College of Emergency Physicians, the national medical society representing emergency medicine.

For more information: www.acep.org

 

 

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init